mRNAワクチン市場レポート：2030年までの動向、予測、競合分析

mRNAワクチンの動向と予測

世界のmRNAワクチン市場は、2024年から2030年までのCAGRが8.3%で、2030年までに推定268億米ドルに達すると予想されます。この市場の主な促進要因は、新しいワクチンや治療薬に対する需要の急増と、慢性疾患や感染症の患者数の増加です。世界のmRNAワクチン市場の将来は、病院・診療所市場や研究施設市場にビジネスチャンスがあり、有望視されています。

mRNAワクチン市場の洞察

Lucintelは、がん免疫療法が予測期間中に最も高い成長を遂げると予測しています。

同市場では、予防接種へのアクセスが便利であること、訓練を受けた医療従事者がいること、高度なヘルスケアインフラが存在することなどから、病院・クリニックへの患者の選好が高まっており、病院・クリニックが引き続き最大セグメントとなります。

北米は、人々の間で感染症の流行が拡大していること、強固なヘルスケア・インフラが存在すること、主要企業が同地域に進出していることなどから、引き続き最大の地域となると思われます。

市場規模・推計：mRNAワクチンの市場規模を金額（10億米ドル）で推計。

動向と予測分析：各種セグメント別、地域別の市場動向（2018年～2023年）と予測（2024年～2030年）。

市場セグメンテーション分析：mRNAワクチンの市場規模をタイプ別、用途別、最終用途別、地域別に金額（10億米ドル）で推計

地域別分析：mRNAワクチン市場の北米、欧州、アジア太平洋地域、その他世界のその他の地域内訳。

成長機会：mRNAワクチン市場のタイプ、用途、最終用途、地域別の成長機会分析。

戦略分析：mRNAワクチン市場のM&A、新製品開発、競合情勢など。

ポーターのファイブフォースモデルに基づく業界の競合強度分析。

本レポートは以下の11の主要な質問に回答しています：

• Q.1.市場セグメントのうち、最も有望かつ高成長な機会は何か？
• Q.2.どのセグメントがより速いペースで成長するのか、またその理由は？
• Q.3.今後成長が加速すると思われる地域とその理由は？
• Q.4.市場力学に影響を与える主な要因は何か？市場における主な課題とビジネスリスクは？
• Q.5.この市場におけるビジネスリスクと競合の脅威は？
• Q.6.この市場における新たな動向とその理由は？
• Q.7.市場における顧客の需要の変化にはどのようなものがありますか？
• Q.8.この市場における新たな開発と、その開発をリードしている企業は？
• Q.9.この市場における主要企業は？主要企業は事業成長のためにどのような戦略的取り組みを進めているのか？
• Q.10.この市場における競合製品にはどのようなものがあり、材料や製品の代替による市場シェア低下の脅威はどの程度ありますか？
• Q.11.過去5年間にどのようなM&Aが行われ、業界にどのような影響を与えましたか？

目次

第1章 エグゼクティブサマリー

第2章 世界のmRNAワクチン市場：市場力学

• イントロダクション、背景、分類
• サプライチェーン
• 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

• マクロ経済動向（2018年～2023年）と予測（2024年～2030年）
• 世界のmRNAワクチン市場動向（2018年～2023年）と予測（2024年～2030年）
• タイプ別の世界のmRNAワクチン市場
  • 自己増幅型mRNAワクチン（SAM）
  • 従来の非増幅型mRNAワクチン
• 用途別の世界のmRNAワクチン市場
  • がん免疫療法
  • アレルギー寛容化
  • 治療用ワクチン
• 最終用途別の世界のmRNAワクチン市場
  • 病院とクリニック
  • 研究
  • その他

第4章 2018年から2030年までの地域別の市場動向と予測分析

• 地域別の世界のmRNAワクチン市場
• 北米のmRNAワクチン市場
• 欧州のmRNAワクチン市場
• アジア太平洋のmRNAワクチン市場
• その他地域のmRNAワクチン市場

第5章 競合の分析

• 製品ポートフォリオ分析
• 運用上の統合
• ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

• 成長機会分析
  • 種類別の世界のmRNAワクチン市場の成長機会
  • 用途別の世界のmRNAワクチン市場の成長機会
  • 最終用途別の世界のmRNAワクチン市場の成長機会
  • 地域別の世界のmRNAワクチン市場の成長機会
• 世界のmRNAワクチン市場の新たな動向
• 戦略的分析
  • 新製品の開発
  • 世界のmRNAワクチン市場の能力拡大
  • 世界のmRNAワクチン市場における合併、買収、合弁事業
  • 認証とライセンシング

第7章 有力企業の企業プロファイル

• Pfizer
• Moderna
• BioNTech
• GlaxoSmithKline
• Daiichi Sankyo

mRNA Vaccine Trends and Forecast

The future of the global mRNA vaccine market looks promising with opportunities in the hospital & clinic and research laboratory markets. The global mRNA vaccine market is expected to reach an estimated $26.8 billion by 2030 with a CAGR of 8.3% from 2024 to 2030. The major drivers for this market are soaring demand for new vaccines and therapeutics and rising cases of chronic and infectious diseases.

A more than 150-page report is developed to help in your business decisions.

mRNA Vaccine by Segment

The study includes a forecast for the global mRNA vaccine by type, application, end use, and region.

mRNA Vaccine Market by Type [Shipment Analysis by Value from 2018 to 2030]:

• Self-Amplifying mRNA Vaccines (SAM)
• Conventional Non-Amplifying mRNA Vaccines

mRNA Vaccine Market by Application [Shipment Analysis by Value from 2018 to 2030]:

• Cancer Immunotherapy
• Allergy Tolerization
• Therapeutic Vaccines

mRNA Vaccine Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals & Clinics
• Research Laboratories
• Others

mRNA Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of mRNA Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies mRNA vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the mRNA vaccine companies profiled in this report include-

• Pfizer
• Moderna
• BioNTech
• GlaxoSmithKline
• Daiichi Sankyo

mRNA Vaccine Market Insights

Lucintel forecasts that cancer immunotherapy is expected to witness highest growth over the forecast period.

Within this market, hospital & clinic will remain the largest segment due to growing patients preference for this facilities because of the convenient access to vaccinations, availability of trained medical personnel, and existence of advanced healthcare infrastructure.

North America will remain the largest regiondue to augmenting prevalence of infectious diseases among population, existence of robust healthcare infrastructure, and presence of key players in the region.

Features of the Global mRNA Vaccine Market

Market Size Estimates: mRNA vaccine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: mRNA vaccine market size by type, application, end use, and region in terms of value ($B).

Regional Analysis: mRNA vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, applications, end uses, and regions for the mRNA vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the mRNA vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the mRNA vaccine market size?

Answer: The global mRNA vaccine market is expected to reach an estimated $26.8 billion by 2030.

Q.2 What is the growth forecast for mRNA vaccine market?

Answer: The global mRNA vaccine market is expected to grow with a CAGR of 8.3% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the mRNA vaccine market?

Answer: The major drivers for this market are soaring demand for new vaccines and therapeutics and rising cases of chronic and infectious diseases.

Q4. What are the major segments for mRNA vaccine market?

Answer: The future of the mRNA vaccine market looks promising with opportunities in the hospital & clinic and research laboratory markets.

Q5. Who are the key mRNA vaccine market companies?

Answer: Some of the key mRNA vaccine companies are as follows:

• Pfizer
• Moderna
• BioNTech
• GlaxoSmithKline
• Daiichi Sankyo

Q6. Which mRNA vaccine market segment will be the largest in future?

Answer: Lucintel forecasts that cancer immunotherapy is expected to witness highest growth over the forecast period.

Q7. In mRNA vaccine market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest regiondue to augmenting prevalence of infectious diseases among population, existence of robust healthcare infrastructure, and presence of key players in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the mRNA vaccine market by type (self-amplifying mRNA vaccines (SAM) and conventional non-amplifying mRNA vaccines), application (cancer immunotherapy, allergy tolerization, and therapeutic vaccines), end use (hospitals & clinics, research laboratories, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global mRNA Vaccine Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global mRNA Vaccine Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global mRNA Vaccine Market by Type
  • 3.3.1: Self-Amplifying mRNA Vaccines (SAM)
  • 3.3.2: Conventional Non-Amplifying mRNA Vaccines
• 3.4: Global mRNA Vaccine Market by Application
  • 3.4.1: Cancer Immunotherapy
  • 3.4.2: Allergy Tolerization
  • 3.4.3: Therapeutic Vaccines
• 3.5: Global mRNA Vaccine Market by End Use
  • 3.5.1: Hospitals & Clinics
  • 3.5.2: Research Laboratories
  • 3.5.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global mRNA Vaccine Market by Region
• 4.2: North American mRNA Vaccine Market
  • 4.2.1: North American mRNA Vaccine Market by Application: Cancer Immunotherapy, Allergy Tolerization, and Therapeutic Vaccines
  • 4.2.2: North American mRNA Vaccine Market by End Use: Hospitals & Clinics, Research Laboratories, and Others
• 4.3: European mRNA Vaccine Market
  • 4.3.1: European mRNA Vaccine Market by Application: Cancer Immunotherapy, Allergy Tolerization, and Therapeutic Vaccines
  • 4.3.2: European mRNA Vaccine Market by End Use: Hospitals & Clinics, Research Laboratories, and Others
• 4.4: APAC mRNA Vaccine Market
  • 4.4.1: APAC mRNA Vaccine Market by Application: Cancer Immunotherapy, Allergy Tolerization, and Therapeutic Vaccines
  • 4.4.2: APAC mRNA Vaccine Market by End Use: Hospitals & Clinics, Research Laboratories, and Others
• 4.5: ROW mRNA Vaccine Market
  • 4.5.1: ROW mRNA Vaccine Market by Application: Cancer Immunotherapy, Allergy Tolerization, and Therapeutic Vaccines
  • 4.5.2: ROW mRNA Vaccine Market by End Use: Hospitals & Clinics, Research Laboratories, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global mRNA Vaccine Market by Type
  • 6.1.2: Growth Opportunities for the Global mRNA Vaccine Market by Application
  • 6.1.3: Growth Opportunities for the Global mRNA Vaccine Market by End Use
  • 6.1.4: Growth Opportunities for the Global mRNA Vaccine Market by Region
• 6.2: Emerging Trends in the Global mRNA Vaccine Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global mRNA Vaccine Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global mRNA Vaccine Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Pfizer
• 7.2: Moderna
• 7.3: BioNTech
• 7.4: GlaxoSmithKline
• 7.5: Daiichi Sankyo